My first trip to India was to participate in a workshop on health technology assessment (HTA) organized by the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) and the Health Intervention and Technology Assessment Program (HITAP) in Puducherry, India on 3-5 October 2019.

In October 2019, the Health Intervention and Technology Assessment Program (HITAP) and the National Health Foundation (NHF), two partners in the Asia Health Technology Assessment (HTA) consortium, were thrilled to take an 8000 km trip to Rwanda to talk all things ‘priority setting’ at a wor

Senegalese delegation with Dr. Yot Teerawattananon, Dr. Wanrudee Isaranuwatchai and Aparna Ananthakrishnan from HITAP We are very honored to have participated in the Health Technology Assessment (HTA) training and symposium.We have seen interestin

On January 28, 2020, PMAC 2020: Accelerating the Progress Towards UHC officially started with side meetings, with one of the very first ones hosted by Health Intervention and Technology Assessment Program (HITAP), titled “Attain & Sustain Health Gains: Incorporating Value-For-Money in the Univer

As economic evaluation methods are constantly changing and developing, it is important to stay abreast of the latest developments so that any beneficial new techniques are utilised, where possible, to maximise the public health impact of health economics and health technology assessment (HT

On 21st September 2020, HITAP joined representatives of the Ministry of Public Health (MOPH) Thailand and the National Health Security Office (NHSO) at the Kenyan Universal Health Coverage (UHC) Fund Taskforce meeting chaired by Mr. Geoffrey Malombe from National Treasury and Dr. Mercy Mwangangi, Ch

Inequalities of health exist across the globe, between genders, socioeconomic groups, ethnicities, geographic regions, and many other characteristics. Health interventions rarely, if ever, have a uniform impact on all the groups that are eligible to receive them, yet most economic evaluations only q

COVID-19 has dominated headlines for over a year now and that doesn’t look likely to change in 2021. Health economic and epidemiological modelling has played a key and well-publicised role in informing policymaking decisions across the globe in response to the COVID-19 pandemic. These models and pro

Beyond expectations – More than 100 abstracts and almost 20 pre-conference session proposals are submitted and will be carefully reviewed by the Scientific Committee. Thank you for your interest and contribution to our network!Results of the review will be sent to the author/s by 30 September 2022 v

The decision-making challenge for reimbursing costly innovative drugs Health technology assessment (HTA) is a multi-disciplinary approach crucial to the decision-making framework for drug reimbursements. It gives evidence of the drug’s cost-effectiveness and affordability to help policymakers decide